158 related articles for article (PubMed ID: 10926384)
1. Clinical aspects of inhaled anticholinergic therapy.
Campbell SC
Respir Care; 2000 Jul; 45(7):864-7. PubMed ID: 10926384
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic bronchodilators.
Witek TJ
Respir Care Clin N Am; 1999 Dec; 5(4):521-36. PubMed ID: 10565879
[TBL] [Abstract][Full Text] [Related]
3. Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease.
On LS; Boonyongsunchai P; Webb S; Davies L; Calverley PM; Costello RW
Am J Respir Crit Care Med; 2001 May; 163(6):1320-5. PubMed ID: 11371395
[TBL] [Abstract][Full Text] [Related]
4. [Clinical aspects of anticholinergic agents].
Friedman M
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
[No Abstract] [Full Text] [Related]
5. [Tiotropium as a controller of bronchoconstriction].
Lubiński W
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():75-6, 78. PubMed ID: 15524023
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
[TBL] [Abstract][Full Text] [Related]
7. [The effect of inhaled ipratropium bromide on airway and lung tissue muscarinic receptors in a rat model of COPD].
Yao W; Wang G; Zhu H; Zhao M
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):95-7. PubMed ID: 11820950
[TBL] [Abstract][Full Text] [Related]
8. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
9. A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats.
Leemans J; Kirschvink N; Bernaerts F; Clercx C; Cambier C; Gustin P
Vet J; 2009 May; 180(2):236-45. PubMed ID: 18294877
[TBL] [Abstract][Full Text] [Related]
10. [Current strategy of bronchodilator therapy for chronic obstructive pulmonary disease (COPD)].
Teramoto S
Nihon Rinsho; 1999 Sep; 57(9):2051-5. PubMed ID: 10497405
[TBL] [Abstract][Full Text] [Related]
11. [Response to inhaled bronchodilators in chronic airway obstruction].
Holten K
Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
[TBL] [Abstract][Full Text] [Related]
12. A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia.
Bar-Aluma BE; Efrati O; Kaufmann H; Palma JA; Norcliffe-Kaufmann L
Lung; 2018 Feb; 196(1):93-101. PubMed ID: 29234869
[TBL] [Abstract][Full Text] [Related]
13. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
14. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacologic therapy for patients with stable chronic obstructive pulmonary disease--emphasis on inhaled agents].
Nishimura K; Ikeda A; Koyama H; Tsukino M; Hajiro T; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():75-8. PubMed ID: 9216189
[TBL] [Abstract][Full Text] [Related]
16. A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD.
Teramoto S; Fukuchi Y; Ouchi Y
Chest; 1996 Jun; 109(6):1666-7. PubMed ID: 8769538
[No Abstract] [Full Text] [Related]
17. Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease.
Yao W; Wang G; Zhu H; Sun Y; Zhao M
Chin Med J (Engl); 2001 Jan; 114(1):80-3. PubMed ID: 11779443
[TBL] [Abstract][Full Text] [Related]
18. An oral selective M3 cholinergic receptor antagonist in COPD.
Lu S; Parekh DD; Kuznetsova O; Green SA; Tozzi CA; Reiss TF
Eur Respir J; 2006 Oct; 28(4):772-80. PubMed ID: 16870658
[TBL] [Abstract][Full Text] [Related]
19. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Ikeda A; Nishimura K; Izumi T
Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208
[No Abstract] [Full Text] [Related]
20. [Pneumology. Should we fear inhaled anticholinergic bronchodilators?].
Rochat T; Janssens JP
Rev Med Suisse; 2009 Jan; 5(186):135-7. PubMed ID: 19238933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
